Medtronic/Minimally Invasive Therapies Group

BIOSYN™ synthetic absorbable sutures are prepared from a synthetic polyester, GLYCOMER 631, composed of glycolide (60%), dioxanone (14%) and trimethylene carbonate (26%). The advanced extrusion process of the molecule of GLYCOMER 631 gives the suture: Excellent initial strength; Excellent in-vivo strength over the critical wound healing period; Excellent knot security; Minimal memory for handling ease. BIOSYN™ synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation including use in ophthalmic surgery, but not for use in cardiovascular or neurological surgery.

BIOSYN™ synthetic absorbable sutures are prepared from a synthetic polyester, GLYCOMER 631, composed of glycolide (60%), dioxanone (14%) and trimethylene carbonate (26%). The advanced extrusion process of the molecule of GLYCOMER 631 gives the suture: Excellent initial strength; Excellent in-vivo strength over the critical wound healing period; Excellent knot security; Minimal memory for handling ease. BIOSYN™ synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation including use in ophthalmic surgery, but not for use in cardiovascular or neurological surgery.

BIOSYN™ synthetic absorbable sutures are prepared from a synthetic polyester, GLYCOMER 631, composed of glycolide (60%), dioxanone (14%) and trimethylene carbonate (26%). The advanced extrusion process of the molecule of GLYCOMER 631 gives the suture: Excellent initial strength; Excellent in-vivo strength over the critical wound healing period; Excellent knot security; Minimal memory for handling ease. BIOSYN™ synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation including use in ophthalmic surgery, but not for use in cardiovascular or neurological surgery.

BIOSYN™ synthetic absorbable sutures are prepared from a synthetic polyester, GLYCOMER 631, composed of glycolide (60%), dioxanone (14%) and trimethylene carbonate (26%). The advanced extrusion process of the molecule of GLYCOMER 631 gives the suture: Excellent initial strength; Excellent in-vivo strength over the critical wound healing period; Excellent knot security; Minimal memory for handling ease. BIOSYN™ synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation including use in ophthalmic surgery, but not for use in cardiovascular or neurological surgery.

Prepared from a synthetic polyester Polyglytone 6211, composed of glycolide, caprolactone, trimethylene carbonate and lactide. The advanced extrusion process of the molecule of Polyglytone 6211 gives the suture strong and secure wound approximation during the critical wound healing period; preditable absorption profile; excellent knot security; excellent handling. For use in general soft tissue approximation and/or ligation, but not for use in cardiovascular or neurological surgery, microsurgery or ophthalmic surgery.

Prepared from a synthetic polyester Polyglytone 6211, composed of glycolide, caprolactone, trimethylene carbonate and lactide. The advanced extrusion process of the molecule of Polyglytone 6211 gives the suture strong and secure wound approximation during the critical wound healing period; preditable absorption profile; excellent knot security; excellent handling. For use in general soft tissue approximation and/or ligation, but not for use in cardiovascular or neurological surgery, microsurgery or ophthalmic surgery.